A 2-Part Webinar Series
Cannabis in an Era of Legalization:
Considerations and Implications for Public Health
Wednesday, February 6th
12:00 - 1:30 PM (Eastern)
This presentation will provide an A to Z of what public health officials need to know in advance of cannabis legalization, including an overview of the state of cannabis policies in the U.S., epidemiologic data on cannabis use patterns to date, scientific information about the health effects of cannabis, areas of public health likely to be most impacted by cannabis legalization, and opportunities for public health to stay engaged as policies change.
- Describe the state of cannabis policy in the United States
- Describe the health effects of cannabis, including what we know and do not know.
- List the most important public health considerations from legalization of adult use of cannabis.
- List at least two actions public health officials/professionals can undertake to help protect public health and safety as cannabis policies change.
Impact of Cannabis Legalization on Tobacco Control Programs:
Secondhand Smoke and Product Overlap
Wednesday, February 13th
12:00 - 1:00 PM (Eastern)
This presentation will provide an overview of how the policies legalizing marijuana have implications for tobacco use and tobacco control programs. Drawing from example of states that have previously legalized marijuana, this session will focus on issues related to: smoke-free and product overlap (specifically electronic devices). The presentation will also cover the appropriate types of public health surveillance issues that can be considered by tobacco control programs.
- Describe the health effects of secondhand cannabis smoke, including what we know and do not know.
- List the four appropriate areas of overlap for tobacco control programs.
- Explain the implications marijuana legalization has for tobacco smoke-free air policies.
Webinars Presented by:
Gillian L. Schauer, PhD, MPH
FREE - NYSPHA members
$10 per webinar - non-members
For each webinar:
1 CHES credit available
1 CPH credit available
Space is limited, registration is required.
Gillian L. Schauer, PhD, MPH
Dr. Gillian Schauer is a Senior Consultant to the National Institute on Drug Abuse and the Centers for Disease Control and Prevention, working on cannabis and tobacco policy, research, and surveillance issues. She has also been a Senior Policy Fellow at the CDC Foundation, where her work focused on cannabis surveillance, policy tracking, research, and state public health technical assistance, including founding the Multi-State Collaborative on Cannabis and Public Health that convenes state health officials to share learnings and challenges. Dr. Schauer has more than 15 years of experience in substance use and health systems-related work. She is a Clinical Instructor at the University of Washington (UW) in the Department of Health Services, and a co-Instructor in the UW Tobacco Studies Program. Her research has focused on cannabis policy and patterns of use, co-use of cannabis and tobacco, and tobacco cessation. She has more than 50 peer-reviewed publications on these topics.
Michael Tynan is a public health analyst at the Centers for Disease Control and Prevention’s Office on Smoking and Health. Michael works with states and communities on tobacco control policy issues and is a subject matter expert on issues such as tobacco prices, smoke-free polices and point of sale policies. Michael previously served as the Policy Officer with the Oregon Public Health Division where he worked on various public health issues, including development of public health administrative rules on marijuana.